-
Something wrong with this record ?
COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project
M. Hájek, D. Chmelař, M. Rozložník, A. Lochmanová, J. Tlapák, T. Vrbová, M. Klugar, J. Klugarová
Language English Country United States
Document type Journal Article
- MeSH
- COVID-19 * prevention & control MeSH
- Hyperbaric Oxygenation * MeSH
- Humans MeSH
- Hospitals MeSH
- Pandemics prevention & control MeSH
- Reproducibility of Results MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
OBJECTIVE: This implementation project compared standard operating procedures, accepted preventive measures, and disinfection procedures between the initial stage of the COVID-19 pandemic (first wave: March 15 to May 31, 2020) and the later stages of the pandemic (second and third waves: September 1, 2020 to January 31, 2021). INTRODUCTION: This project sought to improve compliance with international evidence-based guidelines and clinical standards for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy taking into account the conditions of the local hospital. METHODS: Guided by the JBI evidence implementation framework, seven evidence-based audit criteria were developed for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy. A questionnaire was used to measure compliance in baseline and follow-up audits. RESULTS: Differences between the baseline and follow-up audits were noted for criteria 6 and 7. Criterion 6 increased from 0% to 100% as the hyperbaric facility was equipped with certified ultraviolet-C radiation for air disinfection during the later period, but this equipment was not available in the initial period of the pandemic. Criterion 7 dropped from 100% in the baseline audit to 0% in the follow-up audit because of a significant increase in the operational burden of the treatment capacity of the facility, which made it impossible to comply with the recommended distancing between patients. CONCLUSIONS: Differences were found in preventive measures, disinfection procedures, work organization, and approach to care strategy. The project objectives were met and the implementation strategies proved effective. Larger sample sizes would need be needed to confirm the reproducibility of the results.
Centre of Hyperbaric Medicine Ostrava City Hospital Ostrava Czech Republic
Institute of Aviation Medicine Prague Czech Republic
Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic
Institute of Laboratory Medicine Faculty of Medicine University of Ostrava Ostrava Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000326
- 003
- CZ-PrNML
- 005
- 20240213093117.0
- 007
- ta
- 008
- 240109s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/XEB.0000000000000400 $2 doi
- 035 __
- $a (PubMed)38037449
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Hájek, Michal $u Centre of Hyperbaric Medicine, Ostrava City Hospital, Ostrava, Czech Republic $u Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Centre for Hyperbaric Medicine of Faculty of Medicine University of Ostrava and Ostrava City Hospital, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Cochrane Czech Republic, Czech Republic: A JBI Centre of Excellence, Czech GRADE Network, Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic
- 245 10
- $a COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project / $c M. Hájek, D. Chmelař, M. Rozložník, A. Lochmanová, J. Tlapák, T. Vrbová, M. Klugar, J. Klugarová
- 520 9_
- $a OBJECTIVE: This implementation project compared standard operating procedures, accepted preventive measures, and disinfection procedures between the initial stage of the COVID-19 pandemic (first wave: March 15 to May 31, 2020) and the later stages of the pandemic (second and third waves: September 1, 2020 to January 31, 2021). INTRODUCTION: This project sought to improve compliance with international evidence-based guidelines and clinical standards for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy taking into account the conditions of the local hospital. METHODS: Guided by the JBI evidence implementation framework, seven evidence-based audit criteria were developed for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy. A questionnaire was used to measure compliance in baseline and follow-up audits. RESULTS: Differences between the baseline and follow-up audits were noted for criteria 6 and 7. Criterion 6 increased from 0% to 100% as the hyperbaric facility was equipped with certified ultraviolet-C radiation for air disinfection during the later period, but this equipment was not available in the initial period of the pandemic. Criterion 7 dropped from 100% in the baseline audit to 0% in the follow-up audit because of a significant increase in the operational burden of the treatment capacity of the facility, which made it impossible to comply with the recommended distancing between patients. CONCLUSIONS: Differences were found in preventive measures, disinfection procedures, work organization, and approach to care strategy. The project objectives were met and the implementation strategies proved effective. Larger sample sizes would need be needed to confirm the reproducibility of the results.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a hyperbarická oxygenace $7 D006931
- 650 _2
- $a pandemie $x prevence a kontrola $7 D058873
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 12
- $a COVID-19 $x prevence a kontrola $7 D000086382
- 650 _2
- $a nemocnice $7 D006761
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chmelař, Dittmar $u Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Centre for Hyperbaric Medicine of Faculty of Medicine University of Ostrava and Ostrava City Hospital, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Rozložník, Miroslav $u Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Centre for Hyperbaric Medicine of Faculty of Medicine University of Ostrava and Ostrava City Hospital, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Lochmanová, Alexandra $u Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Centre for Hyperbaric Medicine of Faculty of Medicine University of Ostrava and Ostrava City Hospital, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Tlapák, Jakub $u Institute of Aviation Medicine, Prague, Czech Republic $u Department of Military Surgery, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic
- 700 1_
- $a Vrbová, Tereza $u Cochrane Czech Republic, Czech Republic: A JBI Centre of Excellence, Czech GRADE Network, Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Klugar, Miloslav $u Cochrane Czech Republic, Czech Republic: A JBI Centre of Excellence, Czech GRADE Network, Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Klugarová, Jitka $u Cochrane Czech Republic, Czech Republic: A JBI Centre of Excellence, Czech GRADE Network, Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00210184 $t JBI evidence implementation $x 2691-3321 $g Roč. 21, Suppl. 1 (2023), s. S57-S63
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38037449 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093114 $b ABA008
- 999 __
- $a ok $b bmc $g 2049158 $s 1210020
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 21 $c S1 $d S57-S63 $e 20231201 $i 2691-3321 $m JBI evidence implementation $n JBI Evid Implement $x MED00210184
- LZP __
- $a Pubmed-20240109